Dr. Reddy's plots new assault on U.S. market

Indian drugmaker Dr. Reddy's Laboratories plans to launch about seven new generics in the United States this year and next, including its version of AstraZeneca's reflux drug Prilosec, a company official said in an interview with Reuters. Report

Suggested Articles

name tag
Pharma

Say hello to Viatris: Pfizer's Upjohn, Mylan merger gets a name

Mylan and Pfizer's Upjohn have a name for their pending merger: Viatris. Heard that before? So has Mylan, which owns a subsidiary with the same name.

by Kyle Blankenship
Test tubes
Pharma

Noninvasive tests can advance NASH diagnostics: analysis

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

by Amirah Al Idrus
Amarin Vascepa pill
Pharma

FDA panel to scrutinize placebo in Amarin's Vascepa trial

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.

by Kyle Blankenship